Update on the Safety Profile of Tofacitinib in Rheumatoid Arthritis from Clinical Trials to Real-World Studies: A Narrative Review

Tofacitinib is approved for the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who do not respond adequately or are intolerant to one or more disease-modifying anti-rheumatic drugs. The tofacitinib RA clinical development program included randomized controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvaro-Gracia, Jose María, García-Llorente, Jose Francisco, Valderrama, Mónica, Gomez, Susana, Montoro, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991042/
https://www.ncbi.nlm.nih.gov/pubmed/33245555
http://dx.doi.org/10.1007/s40744-020-00258-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991042/
https://www.ncbi.nlm.nih.gov/pubmed/33245555
http://dx.doi.org/10.1007/s40744-020-00258-9

Ejemplares similares